Tandem Diabetes Care, Inc. ($TNDM) Stock Forecast: Down 5.0% Today

What is Tandem Diabetes Care, Inc.?

Tandem Diabetes Care, Inc. (TNDM) is a company that specializes in diabetes management products and services. The overall market sentiment towards TNDM has been positive due to expectations of beating earnings estimates.

Why is Tandem Diabetes Care, Inc. going down?

TNDM stock is down 5.0% on Jul 31, 2025 15:51

• The bearish movement in TNDM stock today could be due to profit-taking by investors who were anticipating a positive earnings report.
• Despite expectations of beating earnings estimates, market conditions or external factors might have influenced the stock's downward movement.
• Investors may have reacted negatively to any unexpected news or developments within the company that were not captured in the earnings expectations.
• It's possible that market sentiment shifted, leading to a sell-off in TNDM shares despite the positive outlook for earnings.

TNDM Price Chart

TNDM Technical Analysis

TNDM News

Tandem Diabetes Care, Inc. ( TNDM ) Expected to Beat Earnings Estimates: Should You Buy?

Tandem Diabetes Care (TNDM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

https://www.zacks.com/stock/news/2638810/tandem-diabetes-care-inc-tndm-expected-to-beat-earnings-estimates-should-you-buy

Trending Today

Shiba Inu ($SHIB) Crypto Forecast: Down 5.2% Today

XRP ($XRP) Crypto Forecast: Down 5.1% Today

Cardano ($ADA) Crypto Forecast: Down 5.1% Today

Chainlink ($LINK) Crypto Forecast: Down 5.4% Today

Lithia Motors Inc. ($LAD) Stock Forecast: Up 5.1% Today

ONEOK Inc. ($OKE) Stock Forecast: Down 5.0% Today

Transdigm Group Incorporated Inc. ($TDG) Stock Forecast: Down 12.7% Today

Eaton Corporation PLC ($ETN) Stock Forecast: Down 6.7% Today

Palantir Technologies Inc ($PLTR) Stock Forecast: Up 7.2% Today

Pfizer Inc. ($PFE) Stock Forecast: Up 5.0% Today

Tandem Diabetes Care, Inc. Price History

25.01.2025 - TNDM Stock was up 8.4%

• TNDM saw a significant uptrend, possibly driven by heightened expectations and optimistic projections from analysts concerning its Q4 earnings.
• Investors may have responded positively to various non-traditional performance indicators, indicating a belief in the company's robust operational position.
• The increase in TNDM's stock price could be attributed to the favorable momentum in the healthcare industry, with a focus on firms delivering innovative solutions for chronic illnesses like diabetes.

09.06.2025 - TNDM Stock was down 5.1%

• TNDM likely experienced a bearish movement due to overall market sentiment affecting investor confidence.
• The downbeat sales reported by Aehr Test Systems may have contributed to a negative investor outlook on the sector, leading to a ripple effect on TNDM.
• Investors may have reacted to the worse-than-expected sales results, causing a shift towards more cautious trading strategies and selling off positions in companies like TNDM.
• The mixed stock movements in the pre-market session could have added to the uncertainty, prompting investors to take a more risk-averse approach and sell off shares in TNDM.

01.04.2025 - TNDM Stock was up 16.8%

• Tandem Diabetes Care (TNDM) posted a loss in Q1 but outperformed revenue expectations, showcasing strong top-line growth.
• Despite the earnings shortfall, the stock displayed a bullish trend, hinting at investor focus on the revenue beat and future growth possibilities.
• The market appears bullish on TNDM's capability to benefit from the rising demand for diabetes management solutions, fueling the positive movement.
• Investors seem to be optimistic about TNDM's long-term potential in the healthcare sector and are overlooking the short-term loss, contributing to the upbeat market sentiment.

07.02.2025 - TNDM Stock was down 5.2%

• Analyst downgrades on related companies like H.B. Fuller Company may have created a negative sentiment in the market, impacting TNDM as well.
• The downgrade of Beyond, Inc. by a top Wall Street analyst could have led to a broader sell-off in the healthcare technology sector, affecting TNDM's stock price negatively.
• Investors might be reevaluating their positions in healthcare technology stocks following the downgrades, leading to increased selling pressure on TNDM shares.

19.02.2025 - TNDM Stock was up 5.4%

• Tandem Diabetes (TNDM) stock witnessed a bullish movement after the commercial launch of Control-IQ+ technology in the United States.
• The launch of Control-IQ+ technology, compatible with Tandem's insulin pump systems, has likely sparked enthusiasm among investors and consumers.
• The successful introduction of this advanced technology showcases Tandem Diabetes' dedication to innovation and addressing the needs of the diabetes management market, potentially enhancing investor confidence in the company's growth prospects.
• The positive market response indicates the potential for increased sales and market share for Tandem Diabetes as it expands its product line and strengthens its position in the healthcare technology sector.

02.04.2025 - TNDM Stock was up 5.0%

• TNDM stock saw a bullish uptrend despite falling short on Q1 earnings, driven by robust sales growth domestically and internationally.
• The company's improved gross margin suggests enhancing operational efficiency, reflecting positively on investors.
• Exceeding revenue estimates while facing a loss indicates market optimism regarding TNDM's future performance and growth prospects.
• Investors are focusing on revenue beat and sales growth, leading to the upbeat movement in TNDM stock, overshadowing the earnings miss.

30.04.2025 - TNDM Stock was down 5.2%

• The recent earnings report for TNDM was positive, with the stock price increasing by 6.5% since the last report.
• Despite the positive earnings, the market might have reacted bearishly due to profit-taking by investors who saw the recent gains as an opportunity to sell.
• Investors may also be concerned about future growth prospects or external factors impacting the company's performance, leading to the bearish movement today.
• Monitoring upcoming news and developments related to TNDM is important to better understand market sentiment and potential future movements.

31.06.2025 - TNDM Stock was down 5.0%

• The bearish movement in TNDM stock today could be due to profit-taking by investors who were anticipating a positive earnings report.
• Despite expectations of beating earnings estimates, market conditions or external factors might have influenced the stock's downward movement.
• Investors may have reacted negatively to any unexpected news or developments within the company that were not captured in the earnings expectations.
• It's possible that market sentiment shifted, leading to a sell-off in TNDM shares despite the positive outlook for earnings.

10.03.2025 - TNDM Stock was down 5.4%

• TNDM stock experienced strong bearish movement, despite being a significant mover in the previous session.
• Recent trends in earnings estimate revisions could have influenced the stock's decline.
• Market skepticism regarding TNDM's capacity to maintain its recent strength resulted in today's bearish movement.

27.01.2025 - TNDM Stock was down 33.8%

• Tandem Diabetes Care (TNDM) posted a loss in Q4 and missed revenue estimates, disappointing investors.
• The unsatisfactory financial results likely influenced the downward trend in TNDM stock.
• Investors appeared to react unfavorably to the company's lackluster performance across key metrics, leading to a drop in TNDM's stock value.
• Absence of positive signs in TNDM's recent earnings report could have eroded investor trust, contributing to the prevalent bearish market sentiment.

27.01.2025 - TNDM Stock was down 33.9%

• TNDM stock fell in the aftermarket due to a Q4 earnings and revenue miss, with the company reporting lower-than-expected numbers.
• Despite strong sales growth in domestic and international markets, Tandem Diabetes Care's Q4 performance fell short of estimates, resulting in a negative market response.
• The disappointing Q4 results, including earnings and revenue surprises on the downside, likely influenced the bearish movement in TNDM stock today.
• The surge in NeuroPace (NPCE) shares did not impact TNDM's performance, as the focus remained on Tandem Diabetes Care's financial results.

22.06.2025 - TNDM Stock was up 5.2%

• TNDM observed a noteworthy upward movement today, potentially influenced by investors interpreting the recent selling pressure as a buying opportunity.
• The technical analysis indicating TNDM being in oversold territory might have attracted value investors on the lookout for a possible stock price recovery.
• The consensus among financial analysts raising earnings estimates for TNDM might have also played a role in fostering positive sentiment, hinting at a potential uptick in the stock's performance.
• In summary, the amalgamation of technical indicators and analyst outlook may have been key drivers behind the positive movement in TNDM today, as investors aimed to benefit from what they viewed as an undervalued stock.